KASMEJ

Kastamonu Medical Journal regularly publishes internationally qualified issues in the field of Medicine in the light of up-to-date information.

EndNote Style
Index
Original Article
Evaluation of the immature granulocyte count in idiopathic sudden sensorineural hearing loss
Aims: The purpose of our study was to show whether the immature granulocyte count (IGC) can be used as a prognostic marker in idiopathic sudden sensorineural hearing loss (ISSNHL).
Methods: This study is a retrospective case-control clinical study. Patients presenting to our clinic between June 2019 and June 2022, diagnosed with ISSNHL, and receiving the same treatment protocol were investigated. Preoperative complete blood count values of 40 normal individuals with normal hearing who presented to our clinic due to nasal septum deviation were adopted as the control group. Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) (platelet × neutrophil / lymphocyte) values were calculated in addition to IGC values in complete blood counts from the patient and control groups. The patient group was classified into treatment-responsive and non-responsive subgroups according to the results of audiological examinations performed after one month based on Siegel’s criteria. IGC, SII, NRL, and PLT values were compared between all groups.
Results: Comparison of the patient and control group’s complete blood count data revealed higher leukocyte and neutrophil counts, IGC and also NLR, PLR, and SII values in the patient group compared to the control group. However, lymphocyte counts were lower in the patient group. None of the parameters previously emerging as significant in the data of patients with healing and non-healing idiopathic sudden hearing loss were statistically significant, and IGC is of no prognostic value in ISSNHL.
Conclusion: IGC may be a novel and inexpensive indicator of ISSNHL and one easily determined with complete blood count, but it is of no prognostic value in the disease.


1. Amarillo E, Navarro A, Hernández-García E, et al. Intratympanic steroids for combined treatment of idiopathic sudden hearing loss: when is it too late? Acta Oto-Laryngol. 2019,139(7):632-635. doi:10.1080/00016489.2019.1614222
2. Covelli E, Altabaa K, Verillaud B. Intratympanic steroids as a salvage therapy for severe to profound idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2018,138(11):966-971. doi:10.1080/00016489.2018.1497805
3. Huafeng Y, Hongqin W, Wenna Z, et al. Clinical characteristics and prognosis of elderly patients with idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2019,139(10):866-869. doi:10.1080/00016489.201.1641218
4. Zhang Y, Jiang Q, Wu X, et al. The influence of metabolic syndrome on the prognosis of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2019,40(8):994-997. doi:10.1097/MAO.0000000000002352
5. Chen C, Wang M, Wang H, et al. Impact of hyperlipidemia as a coexisting factor on the prognosis of idiopathic sudden sensorineural hearing loss: a propensity score matching analysis. Clin Otolaryngol. 2020,45(1):2-11. doi:10.1111/coa.13421
6. Chung JH, Cho SH, Jeong JH, et al. Multivariate analysis of prognostic factors for idiopathic sudden sensorineu- ral hearing loss in children. Laryngoscope. 2015,125(9):2209-2215. doi:10.1002/lary.25196
7. Chaushu H, Ungar OJ, Abu Eta R, et al. Spontaneous recovery rate of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis. Clin Otolaryngol. 2023,48(3):395-402. doi:10.1111/coa.14036
8. Nonoyama H, Tanigawa T, Shibata R, et al. Red blood cell distribution width predicts prognosis in idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2016,136(11):1137-1140. doi:10.1080/00016489.2016.1195919
9. Kınar A, Ulu S, Bucak A, et al. Can Systemic immune- inflammation index (SII) be a prognostic factor of Bell’s palsy patients?. Neurol Sci. 2021,42(8):3197-3201. doi:10.1007/s10072-020-04921-5
10. Bildirici, M. A., & Kocatürk, İ. Can immature granulocyte (IG), an inflammatory marker, be used in the differential diagnosis of epilepsy and non-epileptic psychogenic seizure?. Kastamonu Med J. 2023,3(3):155-158.
11. Yılmaz U. A New and early marker in the diagnosis of acute complicated appendicitis: immature granulocytes.Ulus Travma Acil Cerrahi Derg. 2018,24(5):434-439.
12. Kaneva AM, Yanov YK, Bojko SG, et al. The atherogenic index (ATH index) as a potential predictive marker of idiopathic sudden sensorineural hearing loss: a case control study. Lipids Health Dis. 2019,18(1):64. doi:10. 1186/s12944-019-1016-5
13. Hiramatsu M, Teranishi M, Uchida Y, et al. Polymorphisms in genes involved in inf- lammatory pathways in patients with sudden sensorineu- ral hearing loss. J Neurogenet. 2012,26(3-4):387-396. doi:10.3109/01677063.2011.652266
14. Chen L, Zhang G, Zhang Z, et al. Neut-rophil-to-lymphocyte ratio predicts diagnosis and prognosis of idiopathic sudden sensorineural hearing loss: a systematic re- view and meta-analysis. Medicine. 2018,97(38):e12492.
15. Rauch SD. Intratympanic steroids for sensorineural hearing loss. Otolaryngol Clin North Am. 2004,37(5):1061-1074.
16. Masuda M, Kanzaki S, Minami S, et al. Correlations of inflammatory biomarkers with the onset and prognosis of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2012,33(7):1142-1150. doi:10. 1097/MAO.0b013e3182635417
17. Seo YJ, Jeong JH, Choi JY, et al. Neutrophil-to-lympho- cyte ratio and platelet-to-lymphocyte ratio: novel markers for diagnosis and prognosis in patients with idiopathic sudden sensorineural hearing loss. Dis Markers. 2014,2024:702807. doi:10.1155/2014/702807
18. Yu J, Li SM, Kong Y, et al. Association of immune-inflammation index with outcome of high-risk acral melanoma patients treated with adjuvant high dose interferon. J Clin Oncol. 2016,34(15_ suppl):e21070.
19. Lolli C, Basso U, Derosa L, et al. Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib. Oncotarget. 2016,7(4): 54564-54571. doi:10.18632/oncotarget.10515
20. Özler GS. Increased neutrophil-lymphocyte ratio in patients with idiopathic sudden sensorineural hearing loss. J Craniofac Surg. 2014,25(3): e260-e263. doi:10.1097/SCS.0000000000000565
21. Koçak HE, Elbistanlı MS, Acıpayam H, et al. Are neutrophil/ lymphocyte and platelet/lym- phocyte ratios related with formation of sudden hearing loss and its prognosis? Eur Ann Otorhinolaryngol Head Neck Dis. 2017,134(6):383-386. doi:10.1016/j.anorl.2016.06.005
22. Ulu S, Ulu MS, Bucak A, et al. Neut-rophil-to-lymphocyte ratio as a new, quick, and reliable indica- tor for predicting diagnosis and prognosis of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2013,34(8): 1400-1404. doi:10.1097/MAO.0b013e31829b57df
23. Gupta K, Tyagi AK, Varshney S, et al. Role of blood investigations in idiopathic unilateral sensorineural hearing loss. Indian J Otolaryngol Head Neck Surg. 2022,74(Suppl 3):3682-3686. doi:10.1007/s12070-021-02413-2
24. Ulu Ş, Kınar A, Bucak A, et al. Systemic immune inflammatory index of patients with idiopathic sudden sensorineural hearing loss: comparison of NLR and PRL Values. Ear Nose Throat J. 2021,100(10):726-730. doi:10. 1177/0145561320924312
25. Kumbul YÇ, Yasan H , Tüz M, et al. Prognostic evaluation of systemic immune inflammation index in sudden idiopathic sensorineural hearing loss. SDÜ Tıp Fak Derg. 2020,27(4):455-461.
Volume 4, Issue 4, 2024
Page : 182-186
_Footer